CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 95 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$404,472
-41.9%
59,047
-12.0%
0.00%0.0%
Q2 2023$695,837
+32.3%
67,101
+3.2%
0.00%0.0%
Q1 2023$526,052
-49.6%
65,025
-2.0%
0.00%
-50.0%
Q4 2022$1,044,603
+1.1%
66,324
+1.1%
0.00%0.0%
Q3 2022$1,033,000
+19.4%
65,616
+5.8%
0.00%
+100.0%
Q2 2022$865,000
-17.7%
61,998
+1.7%
0.00%0.0%
Q1 2022$1,051,000
+8.8%
60,986
-8.2%
0.00%0.0%
Q4 2021$966,000
-15.9%
66,460
+4.1%
0.00%0.0%
Q3 2021$1,149,000
+9.2%
63,821
+6.6%
0.00%0.0%
Q2 2021$1,052,000
+2046.9%
59,896
+26.5%
0.00%
Q1 2020$49,000
-44.3%
47,336
+1.2%
0.00%
Q4 2019$88,000
+72.5%
46,787
-1.4%
0.00%
Q3 2019$51,000
-51.0%
47,4400.0%0.00%
Q2 2019$104,000
-68.7%
47,440
-14.4%
0.00%
-100.0%
Q1 2019$332,000
-19.0%
55,4130.0%0.00%0.0%
Q4 2018$410,000
-31.0%
55,413
+35.5%
0.00%0.0%
Q3 2018$594,000
-27.3%
40,904
-0.0%
0.00%
-50.0%
Q2 2018$817,000
+32.2%
40,907
+16.0%
0.00%
+100.0%
Q1 2018$618,000
-31.6%
35,264
-3.8%
0.00%
-50.0%
Q4 2017$904,000
-2.9%
36,645
+1.6%
0.00%0.0%
Q3 2017$931,000
-3.8%
36,058
+1.0%
0.00%0.0%
Q2 2017$968,000
+46.2%
35,696
+60.8%
0.00%
+100.0%
Q1 2017$662,000
+4.7%
22,196
-4.7%
0.00%0.0%
Q4 2016$632,000
+22.7%
23,296
+15.9%
0.00%0.0%
Q3 2016$515,000
+47.6%
20,096
+6.4%
0.00%0.0%
Q2 2016$349,000
+51.1%
18,896
+54.7%
0.00%
Q1 2016$231,000
-19.5%
12,213
+14.7%
0.00%
-100.0%
Q4 2015$287,00010,6500.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 2,858,569$85,243,00025.08%
Sofinnova Management VIII, L.L.C. 1,539,480$45,907,00024.21%
EcoR1 Capital, LLC 673,100$20,072,0005.07%
Cormorant Asset Management, LP 800,000$23,856,0003.46%
Perceptive Advisors 1,260,847$37,598,0002.14%
NEXTHERA CAPITAL LP 111,500$3,325,0001.70%
Foresite Capital Management III, LLC 140,000$4,175,0001.60%
ACUTA CAPITAL PARTNERS, LLC 200,000$5,964,0001.41%
Rock Springs Capital Management LP 675,000$20,129,0001.16%
CAXTON CORP 13,263$395,0001.13%
View complete list of ACLARIS THERAPEUTICS INC shareholders